Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1993 1
1994 1
1995 5
1996 8
1997 11
1998 19
1999 30
2000 32
2001 33
2002 37
2003 38
2004 51
2005 87
2006 52
2007 57
2008 55
2009 59
2010 78
2011 74
2012 52
2013 64
2014 49
2015 52
2016 43
2017 44
2018 40
2019 51
2020 60
2021 59
2022 46
2023 41
2024 56
2025 45
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,312 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Werth VP, Joly P, Mimouni D, Maverakis E, Caux F, Lehane P, Gearhart L, Kapre A, Pordeli P, Chen DM; PEMPHIX Study Group. Werth VP, et al. N Engl J Med. 2021 Jun 17;384(24):2295-2305. doi: 10.1056/NEJMoa2028564. Epub 2021 May 19. N Engl J Med. 2021. PMID: 34097368 Clinical Trial.
BACKGROUND: Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials. ...RESULTS: Of the 135 patients who underwent randomization, 67 were assigned to receive rituximab and 68 to receive …
BACKGROUND: Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compar …
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K; Japanese Study Group of Kidney Disease in Children. Iijima K, et al. J Am Soc Nephrol. 2022 Feb;33(2):401-419. doi: 10.1681/ASN.2021050643. Epub 2021 Dec 8. J Am Soc Nephrol. 2022. PMID: 34880074 Free PMC article. Clinical Trial.
METHODS: We conducted a multicenter, randomized, double-blind, placebo-controlled trial to examine whether mycophenolate mofetil (MMF) administration after rituximab can prevent treatment failure (FRNS, SDNS, steroid resistance, or use of immunosuppressive agents or …
METHODS: We conducted a multicenter, randomized, double-blind, placebo-controlled trial to examine whether mycophenolate mofetil …
Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis.
Mostafa N, Phan K, Smith S. Mostafa N, et al. J Dermatolog Treat. 2022 Feb;33(1):369-372. doi: 10.1080/09546634.2020.1755416. Epub 2020 Apr 23. J Dermatolog Treat. 2022. PMID: 32281437 Free article.
There have been several reports of the off-label use of mycophenolate mofetil (MMF) in patients with LPP or have developed adverse effects to initial agents. ...
There have been several reports of the off-label use of mycophenolate mofetil (MMF) in patients with LPP or have developed adv …
Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis.
Phan K, Smith SD. Phan K, et al. J Dermatolog Treat. 2020 Dec;31(8):810-814. doi: 10.1080/09546634.2019.1642996. Epub 2019 Aug 1. J Dermatolog Treat. 2020. PMID: 31294617 Free article.
There have been some reports of treatment efficacy of off-label use of mycophenolate mofetil (MMF) in patients with refractory atopic dermatitis or have developed adverse effects to initial systemic agents.Methods: Electronic searches were performed using six databa …
There have been some reports of treatment efficacy of off-label use of mycophenolate mofetil (MMF) in patients with refractory …
Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis.
Ali AM, Abdelrahim ME, AbdelMagid AM. Ali AM, et al. BMC Gastroenterol. 2025 Aug 22;25(1):613. doi: 10.1186/s12876-025-04206-1. BMC Gastroenterol. 2025. PMID: 40846917 Free PMC article.
Traditionally, treatment includes azathioprine (AZA) combined with steroids, but recent studies have highlighted mycophenolate mofetil (MMF) as a potential alternative, particularly for patients who do not respond well to AZA. ...METHODS: A comprehensive systematic …
Traditionally, treatment includes azathioprine (AZA) combined with steroids, but recent studies have highlighted mycophenolate mof …
Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis.
Zhang H, Zhou M, Han X, Yang Y, Yu X. Zhang H, et al. Medicine (Baltimore). 2020 Aug 14;99(33):e21121. doi: 10.1097/MD.0000000000021121. Medicine (Baltimore). 2020. PMID: 32871981 Free PMC article.
BACKGROUD: Mycophenolate mofetil (MMF) has been recommended for the treatment of lupus nephritis (LN). ...
BACKGROUD: Mycophenolate mofetil (MMF) has been recommended for the treatment of lupus nephritis (LN). ...
Efficacy and safety of mycophenolate mofetil versus cyclophosphamide therapy for Henoch schonlein purpura nephritis in children: A meta-analysis.
Wang D, Liu T, Lu J, Li X, Liu X, Xu W. Wang D, et al. Medicine (Baltimore). 2024 Jul 26;103(30):e39059. doi: 10.1097/MD.0000000000039059. Medicine (Baltimore). 2024. PMID: 39058868 Free PMC article.
OBJECTIVE: The objective of this meta-analysis was to compare the efficacy and safety between glucocorticoids combined with mycophenolate mofetil (MMF) versus glucocorticoids combined with cyclophosphamide (CTX) for henoch schonlein purpura nephritis (HSPN) in child …
OBJECTIVE: The objective of this meta-analysis was to compare the efficacy and safety between glucocorticoids combined with mycophenolate …
Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
Yu ZJ, Zhang LL, Huang TT, Zhu JS, He ZB. Yu ZJ, et al. Eur J Gastroenterol Hepatol. 2019 Jul;31(7):873-877. doi: 10.1097/MEG.0000000000001367. Eur J Gastroenterol Hepatol. 2019. PMID: 31150366
OBJECTIVE: To systematically evaluate the efficacy of mycophenolate mofetil (MMF) compared with the standard treatment for autoimmune hepatitis. METHODS: Medline (PubMed), Embase, and Cochrane Library databases were searched between 1966 and June 2018 for studies on …
OBJECTIVE: To systematically evaluate the efficacy of mycophenolate mofetil (MMF) compared with the standard treatment for aut …
Efficacy of mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Wang Y, Ma J, Chang H, Zhang X, Yin L. Wang Y, et al. Mult Scler Relat Disord. 2021 Oct;55:103181. doi: 10.1016/j.msard.2021.103181. Epub 2021 Jul 31. Mult Scler Relat Disord. 2021. PMID: 34365314
The present review aimed to conduct an update systematic review and meta-analysis for the efficacy of mycophenolate mofetil in the treatment of NMOSD and analyze main factors affecting the efficacy of mycophenolate mofetil. ...MeSH include: Neuromyelit …
The present review aimed to conduct an update systematic review and meta-analysis for the efficacy of mycophenolate mofetil in …
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, Ecotiere L, Buchler M, Bouvier N, Schvartz B, Rerolle JP, Heng AE, Couzi L, Duveau A, Morelon E, LeMeur Y, Golbin L, Thervet E, Benotmane I, Fafi-Kremer S. Caillard S, et al. Kidney Int. 2025 Feb;107(2):338-347. doi: 10.1016/j.kint.2024.09.018. Epub 2024 Oct 28. Kidney Int. 2025. PMID: 39490986 Clinical Trial.
All together, 130 KTRs presenting with BKPyV DNAemia were randomized 1:1 into two groups. The EVR group, in which mycophenolate mofetil (MMF) was replaced by EVR along with a decrease in calcineurin inhibitor trough levels and secondly the MMF group, in which the MM …
All together, 130 KTRs presenting with BKPyV DNAemia were randomized 1:1 into two groups. The EVR group, in which mycophenolate mo …
1,312 results